Mo Brooks sold Boston Scientific Corp (NYSE: BSX)
Mo Brooks (R-AL), a U.S. Representative, has disclosed 1 trade in Boston Scientific Corp (BSX) since 2020, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Mo Brooks sold $1,001 - $15,000 of Boston Scientific Corp (NYSE: BSX) on February 5, 2020. Since that trade, BSX is up +7.93% against the S&P 500 up +143.83%, an outperformance of -135.90%.
Data updated
Mo Brooks's BSX trades vs the price
BSX is up +7.93% since Mo Brooks sold on February 5, 2020, versus +143.83% for the S&P 500.
Performance since this trade
All Mo Brooks BSX trades
Mo Brooks & BSX trading FAQ
Is it legal for Mo Brooks to trade Boston Scientific Corp (BSX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Boston Scientific Corp (BSX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Mo Brooks sell BSX?
Mo Brooks disclosed a sale of $1,001 - $15,000 of Boston Scientific Corp (BSX) on February 5, 2020, according to public STOCK Act filings.
How has BSX performed since Mo Brooks's trade?
Since Mo Brooks sold BSX on February 5, 2020, the stock is up +7.93%, versus +143.83% for the S&P 500 over the same period, an outperformance of -135.90%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BSX trades?
Quantellect tracks every disclosed congressional trade in Boston Scientific Corp (BSX) on the Boston Scientific Corp congressional trading page, which aggregates filings across all members of Congress.
Mo Brooks's BSX tradesAll congressional filings for Boston Scientific CorpMo Brooks's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.